| Overall | CMV Reactivation |  | |
---|---|---|---|---|
 | N = 71 | Yes (n = 13, 18.3%) | No (n = 58, 81.7%) | P |
Complications, n (%)&a | 54 (76.1) | 13 (100) | 41 (70.7) | 0.06 |
Blood Transfusion in ICU, n (%) | 52 (73.2) | 12 (92.3) | 40 (69.0) | 0.17 |
Length of IMV (d)b | 13 (8–20) | 25 (20–45) | 10 (8–18) |  < 0.01 |
Hospitalization Expenses (million/¥)a | 0.18 (0.11–0.26) | 0.35 (0.35–0.23) | 0.16 (0.11–0.23) | 0.02 |
Length of Hospital Stay (d) | 29 (17–50) | 50 (27–61) | 28 (17–41) | 0.10 |
ICU Length of Stay (d)b | 14 (9–20) | 27 (20–45) | 12 (8–18) |  < 0.01 |
28Â day All-Cause Mortality, n (%) | 17 (23.9) | 5 (38.5) | 12 (20.7) | 0.32 |
90 day All-Cause Mortality, n (%)b | 20 (28.2) | 9 (69.2) | 11 (19.0) |  < 0.01 |